Teva pledges US$21 million for UK trials, dementia research
Israel’s Teva says it will invest US$20 million in clinical trials and US$1 million in a dementia-research programme in the UK.
Read MoreAuthor: Peter Mansell
Clinipace extends Asian footprint with Choice Pharma merger
US-based digital contract research organisation (dCRO) Clinipace Worldwide has widened its footprint in the key Asian market through a completed merger with pan-Asian CRO Choice Pharma.
Read Mored-Wise bolsters clinical-trial resources with Dootsonic takeover
The local subsidiary of d-Wise Technologies, a US-based company offering business-optimisation solutions for the life-science and healthcare industries, has strengthened its European presence and clinical-trial support offering by acquiring fellow UK technology consultants Dootsonic.
Read MoreIMI’s GETREAL project seeks integrated real-world data
The European Union’s Innovative Medicines Initiative (IMI) has officially launched its multi-stakeholder, €16.3 million GETREAL project, which is looking at new ways to integrate data from real-life settings into drug development.
Read MoreINC Research acquires Middle Eastern CRO MEK Consulting
US-based clinical research organization (CRO) INC Research has extended its global footprint into the Middle East and North Africa (MENA) with the acquisition of MEK Consulting.
Read More- RougeTx launches with $58 million series A financing for HHT therapy
- Lundbeck presents phase 1b data for Lu AF28996 in advanced Parkinson’s disease
- Bespak and SNBL agree global access deal for FDA‑approved nasal device
- NEMLUVIO data show sustained three‑year responses in atopic dermatitis
- SMC accepts AQUIPTA for eligible migraine patients in Scotland
